Nurse Practitioner, Family · Festus, MO
NPI
1245726710
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1400 US Highway 61 Ste 210
Festus, MO, 63028
Phone (636) 933-8880
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
1,098 services
Medicare patients, 2024
198
Average age 69
Drug cost, 2024
$4.0M
6,389 prescriptions
Company payments, 2025
$1,533
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristen Rider was code 99214 (office e&m - established), 422 times for 183 patients. In total Kristen Rider billed 1,098 services in 11 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 422 | 183 | $72.57 | $31K |
| 83036 Blood Count | Office | 303 | 165 | $9.42 | $2,854 |
| 95251 Test - Miscellaneous | Office | 181 | 82 | $20.85 | $3,775 |
| 82962 Clinical Chemistry | Office | 111 | 84 | $3.21 | $356 |
| 82947 Clinical Chemistry | Office | 37 | 26 | $3.85 | $142 |
| 99213 Office E&M - Established | Office | 34 | 31 | $37.51 | $1,275 |
By year: 2022 $48K for 1,571 services; 2023 $49K for 1,421 services; 2024 $39K for 1,098 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 303 | 165 | $9.42 | $2,854 |
| 82962 Clinical Chemistry | 111 | 84 | $3.21 | $356 |
| 82947 Clinical Chemistry | 37 | 26 | $3.85 | $142 |
Medicare prescription drug claims, 2024
In 2024, the drug Kristen Rider prescribed most often to Medicare patients was Ozempic (Semaglutide), with 553 prescriptions and refills. In total Kristen Rider wrote 6,389 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 553 | 671 | 106 | $640K |
| Mounjaro Tirzepatide | 456 | 578 | 90 | $618K |
| Jardiance Empagliflozin | 439 | 739 | 95 | $430K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 352 | 601 | 83 | $405K |
| Trulicity Dulaglutide | 286 | 357 | 60 | $342K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 269 | 380 | 42 | $220K |
| Levothyroxine Sodium Generic | 261 | 561 | 57 | $2,052 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 213 | 391 | 50 | $206K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 181 | 372 | 54 | $27K |
| Atorvastatin Calcium Generic | 176 | 462 | 53 | $1,907 |
| Metformin Hcl Generic | 167 | 402 | 44 | $1,074 |
| Humalog Kwikpen U-100 Insulin Lispro | 130 | 235 | 48 | $41K |
| Metformin Hcl Er Metformin Hcl | 127 | 285 | 34 | $851 |
| Insulin Lispro Generic | 123 | 154 | 29 | $11K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 119 | 156 | 38 | $29K |
Brand drugs: 4,593 claims; generic drugs: 1,243 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristen Rider $1,533 ($1,533 in general payments such as food, travel and fees) from 26 companies. The largest payer was Novo Nordisk Inc with $192.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 14 | $192 |
| Mannkind Corporation MNKD | 7 | $177 |
| Medtronic, Inc. MDT | 3 | $145 |
| Xeris Pharmaceuticals, Inc. | 5 | $86.79 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $78.61 |
| Recordati_rare_diseases_inc. | 1 | $70.67 |
| Corcept Therapeutics CORT | 3 | $69.46 |
| Abbvie Inc. ABBV | 3 | $68.41 |
| Sequel Med Tech, LLC | 3 | $66.58 |
| Beta Bionics, Inc. BBNX | 3 | $61.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.